Marina Udier | PhD

Marina joined Nouscom in 2016 as the Chief Operating Officer from Versant Ventures where she was an Operating Principal. Prior to Versant, Marina was at Novartis Pharma in Basel in various senior [...]

Richard Davis | PHD

Rick joined Nouscom in September 2020 from Johnson and Johnson Innovation where he was the Global Oncology Venture and Transaction Lead. He was Chief Executive Officer of a European clinical [...]

Sven Gogov | MD

Sven Gogov, MD, is an experienced global clinical development leader bringing over 15 years of pharmaceutical oncology experience and regulatory interactions to Nouscom. Sven joined Nouscom in [...]

Elisa Scarselli | MD

Elisa joined Okairos in 2010 as the company’s Clinical Director. Prior to Okairos, she was a Scientist at IRBM / Merck since 1992, where she worked first on Hepatitis C infection and immunity and [...]

Tiffany Muller

Tiffany has 15 years of experience in finance including investments, global treasury, and investor relations. Prior to joining Nouscom in 2019, she held leadership roles with a U.S. based Fortune [...]

Loredana Siani | PHD

Loredana joined Nouscom in 2020 as the Technical Director from Reithera. She has fifteen years of industry experience spanning process development and GMP production of viral vectored vaccines. [...]

Ilaria Cirasola

Ilaria has been involved with Nouscom supporting its founders and the company since its inception. She has more than 15 years of experience in the field of HR and business management. Before [...]